U.S. markets closed

NuVasive, Inc. (NUVA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
68.15-0.17 (-0.25%)
At close: 4:00PM EDT
68.15 0.00 (0.00%)
After hours: 05:18PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close68.32
Open68.40
Bid68.16 x 2900
Ask69.65 x 1100
Day's Range67.39 - 68.62
52 Week Range43.11 - 72.61
Volume373,105
Avg. Volume532,676
Market Cap3.52B
Beta (5Y Monthly)1.32
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • NuVasive Appoints Daniel J. Wolterman as Independent Board Chair
    PR Newswire

    NuVasive Appoints Daniel J. Wolterman as Independent Board Chair

    NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the appointment of Daniel J. Wolterman as independent chair of the NuVasive Board of Directors, effective immediately. Mr. Wolterman succeeds Gregory T. Lucier as the Company's Board chair, following Mr. Lucier's retirement from the Board on May 18, 2021.

  • NuVasive Appoints Juliet C. Cunningham as Vice President of Investor Relations
    PR Newswire

    NuVasive Appoints Juliet C. Cunningham as Vice President of Investor Relations

    NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the appointment of Juliet C. Cunningham as the vice president of Investor Relations, effective immediately. In this role, Ms. Cunningham is responsible for the Company's investor relations program and reports directly to Chief Financial Officer Matt Harbaugh.

  • NuVasive Announces First Quarter 2021 Financial Results
    PR Newswire

    NuVasive Announces First Quarter 2021 Financial Results

    NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended March 31, 2021.